Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Iterum Therapeutics PLC (ITRM) had Normalized Pre-Tax Income of $-4.83M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.89M |
|
$0.34M |
|
$-0.34M |
|
$3.71M |
|
$-3.71M |
|
$-1.12M |
|
$-4.83M |
|
|
Normalized Pre-Tax Income |
$-4.83M |
$-4.89M |
|
$-4.89M |
|
$-4.89M |
|
$-4.89M |
|
$-3.71M |
|
$-3.17M |
|
34.06M |
|
34.06M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$13.51M |
|
$0.02M |
|
$19.46M |
|
$32.98M |
|
$3.63M |
|
$20.70M |
|
$31.90M |
|
$35.53M |
|
$-2.55M |
|
$-21.96M |
|
$-2.55M |
|
35.69M |
|
| Cash Flow Statement Financials | |
$-3.06M |
|
$-0.00M |
|
$-8.39M |
|
$24.16M |
|
$12.69M |
|
$-11.47M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.72 |
|
-- |
|
-- |
|
1.14 |
|
-8.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.64 |
|
-- |
|
-- |
|
191.50% |
|
22.27% |
|
-14.83% |
|
-26.95% |
|
$-0.07 |
|
$-0.09 |
|
$-0.09 |
|